Monoclonal Antibodies Market Growth, Demand and Challenges of the Key Industry Players 2028

1
Global Monoclonal Antibodies Market Research and
Forecast Report 2023-2028




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Monoclonal Antibodies Market Research
Report The latest report by IMARC, titled
Monoclonal Antibodies Market Global Industry
Trends, Share, Size, Growth, Opportunity and
Forecast 2023-2028 " the global monoclonal
antibodies market reached a value of US 207.4
Billion in 2022. Monoclonal antibodies (mAb)
are produced by a single clone of cells or cell
lines and consist of identical antibody
molecules. These antibodies can have monovalent
affinity, binding only to the same epitope. Due
to their site-specificity, these serve as
essential tools to detect or purify substances.
They are being used on a clinical level to
diagnose and treat several diseases. They are
used as probes to identify materials in
laboratories or home-testing kits. Due to their
specificity to unique epitopes, monoclonal
antibodies are widely used for diagnostic and
therapeutic applications for several diseases.
Several manufacturers are focusing on creating
medications from many classifications to treat
various disorders, including cancer and rare
diseases. Monoclonal antibodies, in combination
with chemotherapeutic drugs, are extensively
being used to treat different malignancies. Reque
st Free Sample Report https//www.imarcgroup.com/
monoclonal-antibodies-market/requestsample
4
Report Description and Highlights
Report Description

Global Monoclonal Antibodies Market Trends The
global market is majorly driven by the increasing
prevalence of chronic diseases, such as cancer
and cardiovascular diseases. In line with this,
the rising demand for biologics and the growing
applications of monoclonal antibodies for
targeted therapies are significantly contributing
to the market. This is attributed to the
escalating awareness about such treatments among
patients and physicians. Furthermore, various key
players are undertaking strategic initiatives to
develop and market mAb products. Apart from this,
the heavy investments by top pharmaceutical
companies in genomics research and development
activities are positively influencing the market.
Moreover, the increasing requirement for
effective and affordable therapies for cancer
treatment is catalyzing the market. Besides, an
extensive product pipeline with potential
effective therapies catering to a diverse range
of diseases is propelling the market expansion.
Additionally, the augmenting focus on the
discovery and development of novel monoclonal
antibody therapeutics to offer treatment for
complex and severe diseases is bolstering the
monoclonal antibodies market. On account of the
factors above, the market is anticipated to reach
a value of US 307.8 Billion by 2028, exhibiting
a CAGR of 6.9 during 2023-2028. Looking
forward, the market value is projected to reach a
strong growth during the forecast period
(2023-2028).
5
Report Description and Highlights
Report Description
Market Summary Breakup by Production Method
In Vivo In Vitro Breakup by Sou
rce Murine Chimeric
Humanized Human Breakup by Indication
Cancer Autoimmune Diseases
Inflammatory Diseases Infectious
Diseases Others

6
Report Description and Highlights
Report Description
Breakup by End Use Hospitals
Research Institutes Others Breakup by R
egion North America U
nited States Canada As
ia-Pacific China
Japan India
South Korea Australia
Indonesia Others
Europe Germany
France

7
Report Description and Highlights
Report Description
United Kingdom
Italy Spain
Russia Others
Latin America Brazil
Mexico Others
Middle East and Africa

8
Report Description and Highlights
Report Description

• Competitive Landscape with Key Players
• AbbVie Inc
• Amgen Inc. Biogen Inc. F. Hoffmann-La Roche AG GS
  K plc Johnson Johnson Merck KGaA Novartis AG Nov
  o Nordisk A/S Pfizer Inc. Sanofi S.A. Thermo Fishe
  r Scientific Inc.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/monoclonal-antibodies-m
  arket

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us